Complete Filing Data
Marker Therapeutics, Inc. reported Stockholders Equity of $16.80 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Marker Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 | FY2002 | FY2001 | FY2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$12.2M | -$10.7M | -$8.2M | -$29.9M | -$41.9M | -$28.7M | -$21.4M | -$148.0M | -$11.0M | -$2.5M | -$34.1M | -$30.9M | -$5.5M | -$5.9M | -$2.0M | -$3.5M | -$17.3M | -$2.2M | -$3.9M | -$1.3M | -$985.6K | -$2.7M | -$5.8M | -$2.3M | -$672.0K | -$935.3K |
| Revenue * | $3.5M | $6.6M | $3.3M | $3.5M | $1.2M | $466.8K | $213.2K | $206.0K | $183.1K | |||||||||||||||||
| Research And Development Expense | $11.8M | $13.5M | $10.4M | $12.0M | $27.8M | $18.9M | $12.8M | $8.0M | $5.3M | $3.8M | $1.7M | $189.0K | $697.6K | $1.1M | $203.7K | $290.0K | ||||||||||
| General And Administrative Expense | $4.2M | $4.2M | $7.5M | $11.3M | $12.9M | $10.5M | $10.0M | $24.4M | $6.4M | $4.7M | $4.4M | $3.2M | $2.0M | $1.0M | $305.7K | $203.1K | ||||||||||
| Operating Income Loss | -$12.9M | -$11.1M | -$14.6M | -$19.8M | -$39.5M | -$28.9M | -$22.5M | -$148.2M | -$11.5M | -$8.5M | -$6.2M | -$3.4M | -$2.7M | -$3.3M | -$5.5M | |||||||||||
| Operating Expenses | $16.4M | $17.7M | $17.9M | $23.3M | $40.7M | $29.4M | $22.7M | $148.4M | $11.7M | $8.5M | ||||||||||||||||
| Gains Losses On Restructuring Of Debt | $0.00 | -$135.6K | -$104.6K | -$1.5M | ||||||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$1.19 | -$1.59 | -$2.37 | |||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$1.19 | -$1.59 | -$2.37 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.0M | -$4.0M | -$4.4M | -$2.3M | -$2.2M | -$2.4M | -$3.0M | $2.5M | -$5.0M | -$6.9M | -$9.2M | -$9.9M | -$12.4M | -$10.9M | -$8.8M | -$7.4M | -$6.3M | -$6.5M | -$5.5M | -$5.6M | -$5.3M | -$4.4M | -$4.8M | -$3.2M | -$4.0M | -$1.9M | -$2.4M | -$2.1M | $6.0M | -$4.7M | $28.5M | -$60.2M | -$700.7K | -$1.6M | $753.5K | -$29.7M | -$870.8K | -$1.1M | -$598.6K | -$404.4K | -$1.3M | -$1.3M | ||||
| Revenue * | $1.2M | $861.2K | $349.1K | $1.9M | $1.2M | $1.2M | $257.6K | $762.7K | $1.2M | $999.6K | $790.5K | $964.3K | $0.00 | $466.8K | $0.00 | $0.00 | $0.00 | $206.0K | $183.1K | $0.00 | ||||||||||||||||||||||||||
| Research And Development Expense | $2.3M | $4.2M | $3.1M | $3.5M | $2.3M | $2.6M | $2.0M | $2.4M | $3.4M | $3.6M | $2.9M | $7.0M | $6.8M | $7.4M | $5.6M | $4.8M | $4.3M | $3.8M | $3.1M | $3.2M | $2.8M | $1.9M | $1.8M | $1.6M | $1.6M | $1.2M | $989.1K | $1.1M | $1.2M | $985.8K | $968.8K | $201.2K | $609.4K | $32.5K | $22.5K | $22.5K | $30.0K | $54.4K | $243.0K | $71.1K | $245.8K | $115.5K | $298.0K | $57.5K | $51.4K | $106.6K |
| General And Administrative Expense | $1.0M | $945.2K | $1.4M | $854.7K | $1.1M | $1.2M | $1.4M | $2.5M | $2.2M | $3.2M | $3.1M | $3.7M | $3.2M | $3.6M | $3.1M | $2.6M | $2.5M | $2.8M | $2.5M | $2.7M | $2.8M | $2.6M | $3.1M | $1.6M | $2.5M | $1.2M | $1.4M | $1.6M | $1.2M | $768.0K | $769.2K | $936.9K | $418.8K | $1.4M | $488.4K | $1.2M | $70.5K | $88.1K | $207.3K | $268.3K | $468.2K | $141.9K | $23.9K | $37.0K | $5.1K | $94.1K |
| Operating Income Loss | -$2.1M | -$4.3M | -$4.6M | -$2.4M | -$2.3M | -$2.5M | -$3.2M | -$4.1M | -$4.3M | -$5.8M | -$5.3M | -$9.8M | -$10.0M | -$10.9M | -$8.8M | -$7.4M | -$6.4M | -$6.6M | -$5.7M | -$5.9M | -$5.6M | -$4.4M | -$4.7M | -$3.2M | -$4.0M | -$2.4M | -$2.4M | -$2.7M | -$2.4M | -$1.8M | -$1.7M | -$1.1M | -$1.0M | -$313.3K | -$675.1K | -$796.7K | -$3.1M | -$671.8K | -$701.4K | -$1.1M | -$1.3M | |||||
| Operating Expenses | $3.4M | $5.1M | $5.0M | $4.3M | $3.5M | $3.8M | $3.5M | $4.9M | $5.5M | $6.8M | $6.1M | $10.8M | $10.0M | $10.9M | $8.8M | $7.4M | $6.8M | $6.6M | $5.7M | $5.9M | $5.6M | $4.4M | $4.9M | $3.2M | $4.2M | $2.4M | $2.4M | $2.7M | $2.4M | $1.8M | $1.7M | $1.4M | ||||||||||||||
| Gains Losses On Restructuring Of Debt | $0.00 | $0.00 | -$65.3K | -$70.3K | -$85.6K | -$1.6M | ||||||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.26 | -$0.25 | -$0.27 | -$0.34 | -$0.47 | -$0.48 | -$0.69 | -$0.63 | ||||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.26 | -$0.25 | -$0.27 | -$0.34 | -$0.47 | -$0.48 | -$0.69 | -$0.63 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 | FY2002 | FY2001 | FY2000 | FY1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $16.8M | $18.6M | $14.1M | $19.6M | $44.0M | $27.3M | $44.1M | $59.3M | $3.7M | $6.2M | -$21.4M | -$1.0M | -$8.8M | -$6.0M | -$3.5M | -$3.9M | -$1.8M | -$3.0M | -$1.7M | -$3.0M | -$2.2M | -$2.4M | -$643.7K | $465.8K | -$74.0K | $252.2K | $100.4K |
| Cash | $16.1M | $19.2M | $15.1M | $11.8M | $42.4M | $21.4M | $43.9M | $61.7M | $5.1M | ||||||||||||||||||
| Liabilities Current | $2.3M | $3.5M | $3.1M | $7.8M | $12.9M | $6.4M | $2.0M | $2.8M | $1.5M | $1.7M | $28.0M | $1.2M | $8.8M | $3.8M | $4.0M | ||||||||||||
| Liabilities And Stockholders Equity | $19.1M | $22.0M | $17.1M | $34.4M | $68.1M | $45.6M | $46.4M | $62.1M | $5.2M | $7.9M | $6.6M | $224.4K | $77.0K | $340.2K | $116.4K | ||||||||||||
| Common Stock Value | $16.7K | $10.7K | $8.9K | $8.4K | $8.3K | $50.7K | $45.7K | $45.4K | $10.6K | $8.4K | $5.9K | $20.3K | $1.5K | $52.1K | $40.3K | ||||||||||||
| Assets Current | $19.1M | $22.0M | $17.1M | $16.6M | $46.0M | $24.4M | $45.5M | $62.0M | $5.2M | $7.9M | $224.4K | $77.0K | $340.2K | $25.3K | |||||||||||||
| Retained Earnings Accumulated Deficit | -$459.2M | -$447.0M | -$436.3M | -$428.0M | -$398.1M | -$356.2M | -$327.5M | -$306.1M | -$157.4M | -$145.8M | -$133.5M | -$86.3M | -$55.4M | ||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $1.3M | $1.8M | $1.7M | $2.5M | $11.1M | $6.0M | $1.8M | $2.8M | $1.5M | $1.2M | $967.4K | $693.4K | $3.8M | $794.3K | $809.3K | ||||||||||||
| Assets | $19.1M | $22.0M | $17.1M | $34.4M | $68.1M | $45.6M | $46.4M | $62.1M | $5.2M | $7.9M | $6.6M | $307.9K | $116.4K | ||||||||||||||
| Cash Period Increase Decrease | $56.6M | -$2.7M | $1.3M | $6.4M | $93.4K | $14.8K | $226.7K | -$117.9K | |||||||||||||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $492.4K | $0.00 | -$24.7K | -$26.9M | -$2.6M | -$59.2K | $317.8K | $53.6K | ||||||||||||||||||
| Other Liabilities Current | $1.7M | $1.3M | $0.00 | $492.4K | $492.4K | $492.4K | $259.8K | $141.8K | |||||||||||||||||||
| Liabilities | $2.3M | $3.5M | $3.1M | $14.8M | $24.1M | $18.3M | $2.3M | $2.8M | $1.5M | $1.7M | |||||||||||||||||
| Derivative Liabilities Current | $0.00 | $31.0K | $49.0K | $9.0K | $14.5K | $26.5M | $9.4K | ||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $17.0M | $19.2M | $15.1M | $11.8M | $43.5M | $21.4M | $43.9M | ||||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $16.1M | $19.2M | $15.1M | $11.8M | $42.4M | $21.4M | $43.9M | $61.7M | $5.1M | ||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$2.1M | $4.1M | $3.3M | -$31.7M | $22.1M | -$22.6M | -$17.8M | $56.6M | |||||||||||||||||||
| Other Receivables Net Current | $1.4M | $2.3M | $1.0M | $2.4M | $237.00 | $1.0M | $0.00 | ||||||||||||||||||||
| Interest And Debt Expense | $0.00 | $10.9K | $83.2K | $745.1K | $679.3K | $1.2M | |||||||||||||||||||||
| Operating Lease Right Of Use Asset | $9.8M | $10.8M | $455.2K | $637.0K | |||||||||||||||||||||||
| Assets Noncurrent | $22.2M | $21.2M | $872.7K | $147.7K | |||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $11.2M | $11.9M | $280.2K | ||||||||||||||||||||||||
| Operating Lease Liability Current | $620.5K | $388.8K | $204.1K | ||||||||||||||||||||||||
| Liabilities Noncurrent | $11.2M | $11.9M | $280.2K | ||||||||||||||||||||||||
| Gain Loss On Sale Of Debt Investments | -$59.2K | $317.8K | $53.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $18.4M | $10.5M | $14.5M | $7.4M | $9.7M | $11.8M | $16.7M | $19.0M | $15.9M | $22.6M | $28.0M | $35.7M | $52.3M | $63.2M | $72.5M | $30.6M | $34.5M | $39.5M | $47.9M | $51.4M | $55.6M | $690.5K | $4.1M | $616.0K | $5.9M | $8.6M | $4.1M | $7.5M | -$19.3M | -$25.7M | -$2.6M | -$9.8M | -$1.8M | -$656.2K | -$2.6M | -$5.1M | -$4.8M | -$4.4M | -$3.6M | -$1.8M | ||||||||||||
| Cash | $17.6M | $10.5M | $13.7M | $9.0M | $7.8M | $11.3M | $17.5M | $18.1M | $6.4M | $18.1M | $25.8M | $28.6M | $48.7M | $57.2M | $64.5M | $27.0M | $32.1M | $40.3M | $48.5M | $53.4M | $57.7M | |||||||||||||||||||||||||||||||
| Liabilities Current | $3.3M | $4.3M | $2.5M | $3.5M | $2.0M | $2.3M | $2.8M | $2.9M | $5.2M | $11.3M | $13.5M | $8.2M | $8.2M | $5.7M | $4.1M | $6.0M | $5.0M | $3.2M | $3.2M | $3.2M | $2.9M | $3.7M | $3.7M | $2.3M | $1.8M | $1.6M | $2.0M | $2.2M | $23.1M | $31.5M | $8.8M | $13.1M | $3.3M | $1.3M | $2.6M | $5.3M | $5.0M | $6.1M | $4.4M | $3.7M | $1.4M | |||||||||||
| Liabilities And Stockholders Equity | $21.7M | $14.8M | $17.0M | $10.9M | $11.7M | $14.1M | $19.5M | $22.0M | $27.9M | $41.1M | $52.3M | $55.0M | $71.9M | $80.5M | $88.4M | $48.6M | $48.5M | $42.9M | $51.4M | $55.0M | $59.0M | $4.4M | $7.9M | $2.9M | $7.7M | $10.1M | $6.1M | $9.7M | $3.8M | $5.8M | $6.2M | $3.2M | $1.5M | $643.6K | $35.7K | $150.0K | $185.3K | $87.4K | $60.7K | $94.8K | $92.0K | |||||||||||
| Common Stock Value | $16.7K | $11.3K | $11.2K | $8.9K | $8.9K | $8.9K | $8.9K | $8.8K | $8.8K | $83.6K | $83.6K | $83.5K | $83.1K | $83.1K | $83.0K | $48.0K | $46.6K | $46.5K | $45.7K | $45.5K | $45.5K | $13.8K | $13.6K | $10.6K | $10.5K | $10.2K | $8.5K | $8.4K | $71.4K | $71.0K | $62.9K | $38.0K | $32.6K | $19.6K | $160.0K | $142.4K | $113.7K | $76.4K | $73.9K | $54.3K | $46.8K | |||||||||||
| Assets Current | $21.7M | $14.8M | $17.0M | $10.9M | $11.7M | $14.1M | $19.5M | $22.0M | $10.9M | $22.4M | $29.3M | $31.0M | $51.4M | $60.0M | $67.5M | $30.3M | $34.8M | $42.0M | $50.5M | $54.0M | $58.0M | $4.4M | $7.9M | $2.9M | $7.7M | $10.1M | $6.1M | $3.8M | $5.8M | $6.6M | $6.2M | $3.2M | $643.6K | $35.7K | $185.3K | $87.4K | $40.0K | $66.3K | $52.0K | |||||||||||||
| Retained Earnings Accumulated Deficit | -$457.5M | -$455.5M | -$451.5M | -$443.2M | -$440.9M | -$438.7M | -$433.5M | -$430.5M | -$433.0M | -$424.2M | -$417.3M | -$408.0M | -$388.4M | -$375.9M | -$365.0M | -$347.7M | -$340.4M | -$334.0M | -$322.5M | -$317.0M | -$311.4M | -$170.5M | -$166.2M | -$160.6M | -$154.7M | -$150.8M | -$148.2M | -$144.2M | -$132.3M | -$138.3M | -$103.3M | -$105.7M | -$55.6K | |||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $1.7M | $2.3M | $2.1M | $2.6M | $1.7M | $1.9M | $2.3M | $2.7M | $4.5M | $5.7M | $4.7M | $7.3M | $7.6M | $5.1M | $3.7M | $5.7M | $4.5M | $3.0M | $2.9M | $2.9M | $2.7M | $3.6M | $3.6M | $2.3M | $1.8M | $1.6M | $1.4M | $1.7M | $1.3M | $1.5M | $671.0K | $1.2M | $2.1M | $701.0K | $711.0K | |||||||||||||||||
| Assets | $21.7M | $14.8M | $17.0M | $10.9M | $11.7M | $14.1M | $19.5M | $22.0M | $27.9M | $41.1M | $52.3M | $55.0M | $71.9M | $80.5M | $88.4M | $48.6M | $48.5M | $42.9M | $51.4M | $55.0M | $59.0M | $4.4M | $7.9M | $2.9M | $7.7M | $10.1M | $6.1M | $9.7M | $1.5M | $224.4K | $150.0K | $185.3K | $87.4K | $60.7K | $94.8K | $92.0K | ||||||||||||||||
| Cash Period Increase Decrease | -$4.0M | -$2.3M | -$1.9M | -$854.8K | $1.3M | $45.0K | -$46.2K | -$226.5K | $14.0K | |||||||||||||||||||||||||||||||||||||||||||
| Gains Losses On Extinguishment Of Debt | $0.00 | $0.00 | $0.00 | $492.4K | $0.00 | $0.00 | -$24.7K | -$27.7M | -$168.4K | -$874.4K | $18.8K | $9.9K | $125.4K | -$204.8K | $23.6K | |||||||||||||||||||||||||||||||||||||
| Other Liabilities Current | $328.3K | $656.6K | $411.3K | $903.4K | $292.6K | $354.0K | $367.9K | $0.00 | $0.00 | $492.4K | $492.4K | $492.4K | $492.4K | $492.4K | $492.4K | $492.4K | $492.4K | $492.4K | $416.0K | $366.0K | $303.5K | $206.9K | ||||||||||||||||||||||||||||||
| Liabilities | $3.3M | $4.3M | $2.5M | $3.5M | $2.0M | $2.3M | $2.8M | $2.9M | $12.0M | $18.5M | $24.3M | $19.3M | $19.7M | $17.2M | $15.9M | $18.0M | $14.0M | $3.4M | $3.5M | $3.6M | $3.4M | $3.7M | $3.7M | $2.3M | $1.8M | $1.6M | $2.0M | $1.9M | $3.4M | |||||||||||||||||||||||
| Derivative Liabilities Current | $0.00 | $0.00 | $129.0K | $65.0K | $58.0K | $107.0K | $147.0K | $8.0K | $6.0K | $10.0K | $17.5K | $29.0K | $21.3M | $29.5M | $7.4M | $11.7M | $2.1M | $89.2K | $152.8K | $977.1K | $1.2M | $1.3M | ||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $18.9M | $11.8M | $13.7M | $9.0M | $7.8M | $11.3M | $17.5M | $18.1M | $6.4M | $18.1M | $25.8M | $28.8M | $48.7M | $57.2M | $64.5M | |||||||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $17.6M | $10.5M | $13.7M | $9.0M | $7.8M | $11.3M | $17.5M | $18.1M | $6.4M | $18.1M | $25.8M | $28.6M | $48.7M | $57.2M | $64.5M | $27.0M | $32.1M | $40.3M | $48.5M | $53.4M | $57.7M | |||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$5.5M | -$3.8M | -$5.4M | -$14.7M | $43.2M | -$3.6M | -$4.0M | |||||||||||||||||||||||||||||||||||||||||||||
| Other Receivables Net Current | $1.7M | $1.7M | $2.5M | $744.4K | $2.5M | $1.9M | $83.3K | $1.7M | $1.1M | $1.7M | $627.6K | $2.2K | $243.00 | $286.00 | $1.0M | $1.0M | ||||||||||||||||||||||||||||||||||||
| Interest And Debt Expense | $15.4K | $483.6K | $96.7K | $98.1K | $356.7K | $170.3K | ||||||||||||||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $5.3M | $5.5M | $5.6M | $9.3M | $9.6M | $10.1M | $10.3M | $10.6M | $11.1M | $200.0K | $407.8K | $501.7K | $547.5K | $592.4K | ||||||||||||||||||||||||||||||||||||||
| Assets Noncurrent | $17.0M | $17.8M | $18.7M | $23.0M | $23.9M | $20.5M | $20.4M | $20.9M | $18.2M | $13.8M | $889.9K | $940.6K | $960.7K | $952.7K | ||||||||||||||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $6.8M | $7.0M | $7.2M | $10.8M | $11.0M | $11.4M | $11.6M | $11.7M | $11.9M | $9.0M | $226.1K | $333.5K | $385.2K | $435.2K | $0.00 | |||||||||||||||||||||||||||||||||||||
| Operating Lease Liability Current | $665.1K | $577.2K | $490.4K | $738.4K | $684.0K | $581.6K | $558.7K | $473.1K | $278.3K | $456.1K | $209.1K | $199.3K | $194.5K | $189.8K | $0.00 | |||||||||||||||||||||||||||||||||||||
| Liabilities Noncurrent | $6.8M | $7.0M | $7.2M | $10.8M | $11.0M | $11.4M | $11.6M | $11.7M | $11.9M | $9.0M | $226.1K | $333.5K | $385.2K | $435.2K | $0.00 | |||||||||||||||||||||||||||||||||||||
| Gain Loss On Sale Of Debt Investments | -$574.3K | $9.9K | -$204.8K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $9.9M | $15.0M | $1.1M | $202.1K | $52.6M | $6.7M | $816.5K | $71.2M | $5.7M | $7.8M | $10.8M | $2.3M | $709.3K | $1.4M | $1.5M | $807.1K |
| Operating Cash Flow * | -$12.0M | -$10.9M | -$16.4M | -$27.0M | -$27.3M | -$20.0M | -$18.3M | -$14.5M | -$8.4M | -$6.5M | -$4.3M | -$2.2M | -$694.6K | -$1.3M | -$925.0K | |
| Share Based Compensation | $537.5K | $245.9K | $858.3K | $3.3M | $6.0M | $5.2M | $5.4M | $16.4M | $2.7M | $1.6M | $1.7M | $1.4M | $132.1K | $2.4M | $1.3M | $2.1M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$454.6K | $8.8K | -$718.4K | -$1.3M | $4.1M | $3.0M | -$964.0K | $1.2M | $283.4K | $257.6K | $96.0K | -$145.2K | $1.8M | $2.0M | -$66.1K | $1.2M |
| Stock Issued During Period Value Share Based Compensation | $537.5K | $245.9K | $1.6M | $5.3M | $6.0M | $5.2M | $5.4M | $16.4M | $2.7M | $1.6M | $1.5M | $46.8K | ||||
| Proceeds From Issuance Of Common Stock | $9.9M | $14.9M | $1.0M | $202.1K | $52.6M | $6.2M | $0.00 | $2.3M | $1.9M | $555.0K | $683.5K | |||||
| Increase Decrease In Prepaid Expense | -$504.4K | -$861.1K | -$104.1K | $426.7K | $531.5K | $1.4M | $90.6K | -$19.0K | $1.3K | -$13.7K | $67.5K | |||||
| Increase Decrease In Derivative Liabilities | -$31.0K | -$18.0K | $40.0K | -$5.5K | -$5.9M | $27.9M | -$581.00 | |||||||||
| Net Cash Provided By Used In Investing Activities | $18.7M | -$4.9M | -$3.1M | -$9.3M | -$375.0K | -$147.7K | $0.00 | |||||||||
| Proceeds From Warrant Exercises | $550.0K | $758.7K | $4.4M | $619.6K | $5.5M | $9.2M | ||||||||||
| Increase Decrease In Accrued Interest Receivable Net | $1.3M | -$1.4M | $2.4M | -$1.0M | -$55.6K | -$52.0K | $108.2K | |||||||||
| Proceeds From Stock Options Exercised | $62.2K | $90.5K | $3.1K | $0.00 | $57.7K | $18.1K | $0.00 | $18.1K | $0.00 | |||||||
| Proceeds From Convertible Debt | $418.0K | $738.0K | $602.0K | $724.5K | $138.9K | |||||||||||
| Increase Decrease In Fair Value Of Unhedged Derivative Instruments | $536.5K | $668.7K | $3.4M | |||||||||||||
| Increase Decrease In Other Operating Liabilities | $76.4K | $156.2K | $118.0K | $96.1K | ||||||||||||
| Increase Decrease In Deferred Charges | $24.0K | $5.2K | -$58.8K | $65.9K | ||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$67.5K | $55.9K | $30.7K | |||||||||||||
| Depreciation Depletion And Amortization | $2.8M | $2.1M | $485.6K | $105.1K | ||||||||||||
| Increase Decrease In Operating Lease Liability | -$513.9K | -$388.8K | -$173.3K | -$185.2K | ||||||||||||
| Proceeds From Short Term Debt | $32.2K | $3.0K | $425.0K | |||||||||||||
| Payments To Acquire Property Plant And Equipment | $375.0K | $147.7K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q1 2015 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $505.00 | $49.1K | $620.0K | $0.00 | $52.7M | $550.0K | $63.1K | $18.1K | $0.00 | -$25.0K | $2.3M | $418.0K | $425.1K | $105.9K | $418.4K | |||||||||||||||||||||||||||
| Operating Cash Flow * | -$5.5M | -$3.8M | -$5.9M | -$12.2M | -$8.1M | -$4.1M | -$3.9M | -$2.3M | -$1.9M | -$829.8K | -$1.0M | -$373.0K | -$471.3K | -$332.4K | -$404.4K | |||||||||||||||||||||||||||
| Share Based Compensation | $379.1K | $79.4K | $659.9K | $1.6M | $1.5M | $1.7M | $1.4M | $1.3M | $1.4M | $1.3M | $1.2M | $1.4M | $1.5M | $851.0K | $960.0K | $136.2K | $1.7M | $271.0K | $376.3K | $800.0K | $331.0K | $214.3K | $3.8K | $690.0K | $83.4K | $163.5K | $458.5K | |||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $336.1K | $204.5K | $111.2K | -$4.0M | -$1.5M | $1.2M | -$27.6K | $792.8K | $224.3K | $678.6K | $10.0K | $158.9K | $539.3K | $24.3K | -$236.8K | |||||||||||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $33.3K | $14.0K | $379.1K | $53.3K | $62.6K | $79.4K | $175.0K | $604.9K | $659.9K | $1.5M | $1.5M | $1.6M | $1.5M | $1.7M | $1.4M | $1.3M | $1.4M | $1.3M | $1.2M | $1.4M | $1.5M | $851.3K | $960.3K | $136.2K | $376.3K | |||||||||||||||||
| Proceeds From Issuance Of Common Stock | $620.0K | $0.00 | $52.7M | $0.00 | $2.3M | $236.0K | $85.0K | |||||||||||||||||||||||||||||||||||
| Increase Decrease In Prepaid Expense | -$71.1K | -$36.5K | -$288.4K | -$95.0K | $189.7K | $74.7K | $77.9K | $107.4K | -$31.2K | |||||||||||||||||||||||||||||||||
| Increase Decrease In Derivative Liabilities | $0.00 | -$31.0K | $9.0K | -$1.0K | $3.0K | $3.0M | -$327.4K | $338.3K | ||||||||||||||||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$112.6K | -$2.5M | -$1.4M | -$99.8K | -$223.1K | $0.00 | ||||||||||||||||||||||||||||||||||||
| Proceeds From Warrant Exercises | $0.00 | $550.0K | $5.4K | $0.00 | ||||||||||||||||||||||||||||||||||||||
| Increase Decrease In Accrued Interest Receivable Net | $112.1K | $823.6K | -$1.3M | $1.9K | $308.00 | -$31.6K | $4.0K | $0.00 | ||||||||||||||||||||||||||||||||||
| Proceeds From Stock Options Exercised | $49.1K | $57.7K | $18.1K | $0.00 | ||||||||||||||||||||||||||||||||||||||
| Proceeds From Convertible Debt | $418.0K | $504.5K | ||||||||||||||||||||||||||||||||||||||||
| Increase Decrease In Fair Value Of Unhedged Derivative Instruments | $266.1K | $781.3K | $526.2K | $121.4K | $352.1K | $71.1K | $46.0K | -$217.4K | -$245.0K | $1.5M | ||||||||||||||||||||||||||||||||
| Increase Decrease In Other Operating Liabilities | $27.5K | $43.8K | $34.5K | |||||||||||||||||||||||||||||||||||||||
| Increase Decrease In Deferred Charges | -$10.6K | -$3.8K | -$91.1K | |||||||||||||||||||||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $357.6K | -$71.1K | $104.0K | -$15.2K | ||||||||||||||||||||||||||||||||||||||
| Depreciation Depletion And Amortization | $818.2K | $576.3K | $502.7K | $35.3K | $10.5K | $0.00 | ||||||||||||||||||||||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$127.8K | -$148.6K | -$64.3K | -$49.2K | -$44.6K | |||||||||||||||||||||||||||||||||||||
| Proceeds From Short Term Debt | ||||||||||||||||||||||||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $99.8K | $223.1K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.79 | -$1.19 | -$0.94 | -$3.58 | -$5.47 | -$0.61 | -$0.47 | -$7.75 | -$1.16 | -$0.72 | -$9.30 | -$2.00 | -$4.87 | -$0.09 | -$0.04 | -$0.09 |
| Common Stock Shares Authorized | 30.0M | 30.0M | 30.0M | 30.0M | 15.0M | 150.0M | 150.0M | 150.0M | 150.0M | 41.7M | 41.7M | 500.0M | 500.0M | 150.0M | 150.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 16.7M | 10.7M | 8.9M | 8.4M | 8.3M | 50.7M | 45.7M | 45.4M | 10.6M | 8.4M | 5.9M | 20.3M | 1.5M | 52.1M | 40.3M | |
| Common Stock Shares Issued | 16.7M | 10.7M | 8.9M | 8.4M | 8.3M | 50.7M | 45.7M | 45.4M | 10.6M | 8.4M | 5.9M | 20.3M | 1.5M | 40.3M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 47.0M | 45.6M | 19.1M | 9.5M | 43.9M | 15.5M | 1.1M | |||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 15.3M | 9.0M | 8.8M | 8.4M | 7.7M | 47.0M | 9.5M | 7.4M | 3.7M | |||||||
| Weighted Average Number Of Shares Outstanding Basic | 15.3M | 9.0M | 8.8M | 8.4M | 7.7M | 47.0M | 9.5M | 6.9M | 3.7M | |||||||
| Earnings Per Share Basic | $-0.79 | $-1.19 | $-0.94 | $-3.58 | $-5.47 | $-0.61 | $-1.16 | $-0.36 | $-9.30 | |||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$0.29 | -$0.40 | -$0.26 | -$0.25 | -$0.27 | -$0.34 | $0.29 | -$0.57 | -$0.83 | -$1.11 | -$1.19 | -$0.15 | -$0.13 | -$0.16 | -$0.16 | -$0.14 | -$0.14 | -$0.12 | -$0.12 | -$0.12 | -$0.32 | -$0.41 | -$0.30 | -$0.39 | -$0.22 | -$0.29 | -$0.29 | $0.35 | -$0.81 | $4.23 | -$1.80 | -$0.03 | -$0.09 | $0.05 | -$3.89 | -$0.76 | -$0.87 | -$0.01 | -$0.04 | -$0.01 | -$0.01 | -$0.03 | -$0.03 | ||||
| Common Stock Shares Authorized | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 41.7M | 41.7M | 41.7M | 41.7M | 41.7M | 41.7M | 41.7M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | |||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Outstanding | 16.7M | 11.3M | 11.2M | 8.9M | 8.9M | 8.9M | 8.8M | 8.8M | 8.8M | 83.6M | 83.6M | 83.5M | 83.1M | 83.1M | 83.0M | 48.0M | 46.6M | 46.5M | 45.7M | 45.5M | 45.5M | 13.8M | 13.6M | 10.6M | 10.5M | 10.2M | 8.5M | 8.4M | 71.4M | 71.0M | 62.9M | 38.0M | 32.6M | 19.6M | 16.8M | 144.3M | 76.4M | 76.4M | 73.9M | 54.3M | 46.8M | |||||||
| Common Stock Shares Issued | 16.7M | 11.3M | 11.2M | 8.9M | 8.9M | 8.9M | 8.8M | 8.8M | 8.8M | 83.6M | 83.6M | 83.5M | 83.1M | 83.1M | 83.0M | 48.0M | 46.6M | 46.5M | 45.7M | 45.5M | 45.5M | 13.8M | 13.6M | 10.6M | 10.5M | 10.2M | 8.5M | 8.4M | 71.4M | 71.0M | 62.9M | 38.0M | 32.6M | 19.6M | 16.8M | 144.3M | 115.6M | 76.4M | 73.9M | 54.3M | 52.1M | 46.8M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 10.0M | 10.0M | ||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 83.0M | 56.5M | 46.9M | 46.6M | 46.1M | 45.7M | 45.5M | 45.5M | 13.7M | 11.8M | 10.6M | 10.2M | 8.6M | 8.4M | 5.9M | 33.5M | 27.6M | 17.3M | 15.5M | 7.6M | 1.3M | 1.0M | 80.7M | 52.5M | ||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 16.8M | 14.0M | 11.1M | 8.9M | 8.9M | 8.9M | 8.8M | 8.8M | 8.7M | 8.4M | 8.4M | 8.3M | 83.1M | 83.0M | 56.5M | 46.9M | 10.2M | 8.6M | 7.3M | 6.5M | 6.7M | 33.5M | 17.3M | 73.1M | 47.2M | |||||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 16.8M | 14.0M | 11.1M | 8.9M | 8.9M | 8.9M | 8.8M | 8.8M | 8.7M | 8.4M | 8.4M | 8.3M | 83.1M | 83.0M | 56.5M | 46.9M | 10.2M | 8.6M | 7.3M | 5.9M | 4.0M | 33.5M | 17.3M | |||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.12 | $-0.29 | $-0.40 | $-0.26 | $-0.25 | $-0.27 | $-0.34 | $0.29 | $-0.57 | $-0.83 | $-1.11 | $-1.19 | $-0.15 | $-0.13 | $-0.16 | $-0.39 | $-0.22 | $-0.29 | $1.01 | $7.04 | $-1.80 | $-0.09 | ||||||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2004 | FY2003 | FY2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $476.0M | $465.6M | $450.3M | $447.6M | $442.1M | $383.5M | $371.6M | $365.4M | $161.1M | $152.0M | $112.1M | $85.3M | $46.7M | ||||||
| Derivative Gain Loss On Derivative Net | $31.0K | $18.0K | -$40.0K | $5.5K | $5.9M | -$27.9M | $581.00 | ||||||||||||
| Investment Income Interest | $594.2K | $437.0K | $539.2K | $248.1K | $5.7K | $148.7K | $1.1M | $253.7K | $0.00 | ||||||||||
| Prepaid Expense Current | $483.7K | $988.1K | $1.8M | $2.5M | $2.1M | $1.5M | $141.7K | $51.2K | $70.1K | $68.8K | $82.5K | $15.0K | |||||||
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | $775.00 | -$53.0K | $5.9K | -$7.9K | $10.2K | -$1.2K | ||||||||||||
| Professional Fees | $489.5K | $437.8K | $1.2M | ||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $62.2K | $90.5K | $3.1K | $57.7K | $18.1K | $18.1K | $205.1K | $1.4M | $51.0K | ||||||||||
| Service Management Costs | $295.6K | $248.4K | $329.2K | ||||||||||||||||
| Stock Issued During Period Value New Issues | $9.9M | $36.9K | $1.0M | $202.1K | $52.6M | $6.2M | $3.1M | ||||||||||||
| Exercise Of Warrants Amount | $550.0K | $758.7K | $4.4M | $666.7K | $5.5M | $9.2M | |||||||||||||
| Consulting Fees | $182.8K | $179.3K | $88.2K | ||||||||||||||||
| Due To Related Parties Current | $369.3K | $322.9K | $259.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $475.8M | $466.0M | $465.9M | $450.6M | $450.6M | $450.5M | $450.2M | $449.5M | $448.9M | $446.7M | $445.2M | $443.7M | $440.6M | $439.1M | $437.4M | $378.3M | $374.8M | $373.5M | $370.3M | $368.4M | $367.0M | $171.2M | $170.3M | $161.2M | $160.7M | $159.3M | $152.4M | $151.7M | $112.9M | $112.5M | $100.6M | $95.9M | $85.5M | $84.5M | $81.2M | $46.4M | $46.0M | $43.5M | |||||||||||
| Derivative Gain Loss On Derivative Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $31.0K | -$64.0K | -$7.0K | -$9.0K | $40.0K | -$139.0K | $1.0K | $4.0K | $7.5K | -$3.0K | $684.0K | $8.2M | -$3.0M | $30.3M | -$59.1M | $327.4K | -$74.1K | $352.8K | -$338.3K | |||||||||||||||||||||||||
| Investment Income Interest | $138.1K | $128.0K | $162.5K | $91.7K | $115.4K | $156.2K | $218.1K | $35.1K | $84.7K | $99.8K | $35.8K | $3.1K | $791.00 | $2.4K | $1.5K | $4.7K | $15.9K | $127.0K | $259.2K | $310.2K | $328.5K | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||
| Prepaid Expense Current | $1.2M | $1.4M | $917.0K | $1.9M | $2.1M | $2.4M | $2.7M | $2.8M | $2.2M | $2.7M | $2.8M | $2.0M | $2.4M | $2.6M | $1.7M | $1.9M | $491.5K | $216.4K | $97.0K | $108.7K | $129.0K | $96.5K | $179.2K | $177.5K | $111.7K | $21.4K | $37.6K | $30.0K | $15.0K | $15.0K | |||||||||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | $0.00 | $0.00 | $775.00 | -$6.6K | -$7.2K | $17.3K | -$7.8K | -$6.9K | -$8.0K | $2.9K | |||||||||||||||||||||||||||||||||||||||
| Professional Fees | $305.4K | $122.6K | $69.9K | $118.7K | $83.7K | $21.8K | $113.0K | $74.1K | $36.2K | $164.9K | $116.0K | $278.1K | |||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $1.7K | $7.7K | $49.1K | $84.6K | $736.00 | $3.1K | $57.7K | $18.1K | |||||||||||||||||||||||||||||||||||||||||
| Service Management Costs | $58.5K | $58.5K | $58.5K | $22.5K | $22.5K | $80.1K | $62.1K | $62.1K | $62.1K | $74.8K | |||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $9.9M | $36.9K | $394.7K | $620.0K | $63.6K | $52.6M | $2.2M | ||||||||||||||||||||||||||||||||||||||||||
| Exercise Of Warrants Amount | $550.0K | $753.4K | $5.4K | $83.1K | $4.3M | ||||||||||||||||||||||||||||||||||||||||||||
| Consulting Fees | $51.0K | $36.4K | $57.3K | $62.5K | $43.8K | $25.0K | $50.5K | $26.7K | |||||||||||||||||||||||||||||||||||||||||
| Due To Related Parties Current | $2.5M | $5.1M | $8.0M | $0.00 | $381.8K | $263.8K | $373.3K | $281.5K | $293.8K | $251.1K |
Most recent annual filing with the SEC: March 18, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.